{"id":3631,"date":"2000-06-15T21:55:24","date_gmt":"2000-06-15T20:55:24","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=3631"},"modified":"2014-07-01T12:58:13","modified_gmt":"2014-07-01T12:58:13","slug":"what-is-armenicum","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/3631","title":{"rendered":"What is Armenicum?"},"content":{"rendered":"<p><strong>Armenicum is an anti-HIV therapy currently being studied in Armenia and other countries from the former Soviet Union.<\/strong><\/p>\n<p>The product is supposed to have been developed as part of an anti-germ\/chemical warfare inoculation for Soviet troops. After the break up of the Soviet Union, the Armenian facility that developed the inoculations fell into disuse, and its &#8216;products&#8217; became the property of the Armenian government. Armenicum was one of these products. At some point, the antiviral properties of Armenicum were &#8216;discovered.&#8217; However, there is no data available to suggest any in vitro or in vivo anti-HIV activity. Anecdotal information reports that several Americans have taken this therapy including two men from San Francisco. The dosing regimen was similar to that of IL-2. The product was given by infusion for several hours each day for five days. Then after a three-week interruption, the process was repeated three more times. The reported side effects were similar to those reported for IL-2 therapy: fever, chills, aching and fatigue. At latest report, the two San Francisco men have had no positive response to therapy.<\/p>\n<p>Source: Excerpts From Hotline Memos of April 2000, Project Inform.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Armenicum is an anti-HIV therapy currently being studied in Armenia and other countries from the former Soviet Union. The product is supposed to have been developed as part of an anti-germ\/chemical warfare inoculation for Soviet troops. After the break up &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-3631","post","type-post","status-publish","format-standard","hentry","category-other-news"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/3631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=3631"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/3631\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=3631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=3631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=3631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}